Live tape
Top 8, mentions 7d12,694TSLA3,043 mentions▲ +0.05SPCX2,537 mentions▲ +0.08GOOGL1,670 mentions▲ +0.03META1,497 mentions▲ +0.05NVDA997 mentions▲ +0.07CRWV987 mentions▲ +0.04QQQ987 mentions▲ +0.05NFLX976 mentions▲ +0.03

Equity · Healthcare

MRVI

NASDAQ

Maravai LifeSciences Holdings (MRVI)

$7.65 +3.80% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 24, 2026
Price · Chart
44 sessions
$10 $4 24 Jul 24 Sep

The line runs $7 on 24 July through $7.65 on 24 September, on a scale from $4 to $10. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 44 sessions, 24 Jul – 24 Sep 2026
Market cap $1.1B
52-week range $2.69 – $9
Avg volume 308.8K

as of Sep 24, 2026

Maravai LifeSciences Holdings (MRVI) insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 8 Oct 2026

In the 90 days to 22 Oct 2026, no Maravai LifeSciences Holdings insider bought or sold shares on the open market; all 6 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Open-market buys 0
Open-market sells 0
Non-trade filings 6

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Oct 2026 Brust Bernd Chief Executive Officer Tax withheld 29,250 $217K
30 Sep 2026 Asarpota Rajesh Chief Financial Officer Tax withheld 5,465 $42K
08 Sep 2026 Brust Bernd Chief Executive Officer Tax withheld 29,250 $214K
31 Aug 2026 Asarpota Rajesh Chief Financial Officer Tax withheld 5,465 $42K
10 Aug 2026 Brust Bernd Chief Executive Officer Tax withheld 29,250 $182K
30 Jul 2026 Asarpota Rajesh Chief Financial Officer Tax withheld 5,465 $36K

Maravai LifeSciences Holdings (MRVI) reported financials

SEC EDGAR XBRL SEC EDGAR

Maravai LifeSciences Holdings reported revenue of $185.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$130.8M.

Figure Reported Period
Revenue $185.7M 31 Dec 2025 fiscal year
Net income −$130.8M 31 Dec 2025 fiscal year
Diluted EPS −$0.90 31 Dec 2025 fiscal year
Total assets $603.7M 30 Jun 2026 at period end
Total equity $204.6M 30 Jun 2026 at period end

Maravai LifeSciences Holdings (MRVI) earnings

SEC EDGAR

Maravai LifeSciences Holdings last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.08; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.08 $51M
31 Mar 2026 Q1 2026 −$0.02 $66M
31 Dec 2025 FY 2025 −$0.90 $186M
30 Sep 2025 Q3 2025 −$0.18 $42M
30 Jun 2025 Q2 2025 −$0.27 $47M
31 Mar 2025 Q1 2025 −$0.21 $47M
31 Dec 2024 FY 2024 −$1.05 $259M
30 Sep 2024 Q3 2024 −$0.68 $69M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Maravai LifeSciences Holdings (MRVI) institutional holders (13F)

SEC Form 13F SEC EDGAR

9 of the 45 institutional funds we track reported a Maravai LifeSciences Holdings position for the quarter ended 30 Jun 2026 — a combined $131.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Added +294.6% shares 6,508,220 $40.6M
Renaissance Technologies Held (±25%) +8.0% shares 4,606,491 $28.7M
Two Sigma Investments Added +42.8% shares 2,255,820 $14.1M
Citadel Advisors Added +43.0% shares 2,122,598 $13.2M
Point72 Asset Management Trimmed −37.4% shares 2,005,579 $12.5M
Tudor Investment Corp Added +365.9% shares 1,849,079 $11.5M
Marshall Wace Trimmed −29.3% shares 1,471,477 $9.2M
Man Group New position 158,429 $989K
AQR Capital Management Held (±25%) +2.8% shares 84,821 $529K

Congressional trades in Maravai LifeSciences Holdings (MRVI)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Maravai LifeSciences Holdings is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.

Date Member Type Amount
10 Apr 2023 filed 19 May 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

Maravai LifeSciences Holdings (MRVI): frequently asked questions

From live data

Have Maravai LifeSciences Holdings insiders bought or sold shares recently?

In the 90 days to 22 Oct 2026, no Maravai LifeSciences Holdings insider bought or sold shares on the open market; all 6 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

How many institutions hold Maravai LifeSciences Holdings?

9 of the 45 institutional funds we track reported a Maravai LifeSciences Holdings position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

When did Maravai LifeSciences Holdings last report earnings?

Maravai LifeSciences Holdings last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.08; no next date is announced in SEC filings yet.

What exchange is Maravai LifeSciences Holdings listed on?

Maravai LifeSciences Holdings trades on NASDAQ under the ticker MRVI.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SEC EDGARValuation computed from SEC EDGAR filings